HealthcareAI Research11 min reading time

Introducing new capabilities to GPT-Rosalind

Open AI News
Read full post
OpenAI has updated its GPT-Rosalind model to integrate GPT-5.5's advanced coding and tool-use abilities with enhanced expertise in drug discovery, medicinal chemistry, and genomics. The model shows improved performance on complex life sciences tasks and is now available in research preview for select organizations. OpenAI also introduced LifeSciBench, a comprehensive benchmark to evaluate life sciences research capabilities across multiple workflow areas.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI
Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources